Article

Take these steps to reduce IRS audit risk

New screening techniques will help IRS decide which tax returns are trulyin errorThe good news about the Internal Revenue Service is that its rate ofaudits has been steadily declining in recent years. The bad news is thatthe IRS's current budget allocates more funds to "taxpayer compliance."

Related Videos
Oliver Sartor, MD, is featured in this series.
Diverse group of doctors | © Flamingo Images - stock.adobe.com
Man talking with a doctor | Image Credit: © RFBSIP - stock.adobe.com
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
UGN-102 data published in Journal of Urology as FDA weighs NMIBC approval
October 28th 2024

UGN-102 data published in Journal of Urology as FDA weighs NMIBC approval

Hannah Clarke
The phase 3 ENVISION trial met its primary end point by demonstrating a 79.6% complete response rate at 3 months following the first instillation of the therapy.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
FDA approves oral sulopenem for uncomplicated urinary tract infection
Published: October 25th 2024 | Updated: October 25th 2024

FDA approves oral sulopenem for uncomplicated urinary tract infection

Hannah Clarke
The approval is supported by data from the phase 3 SURE 1 and REASSURE trials.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
July 24th 2024

Speaking of Urology: Dr. Winter on the use of vaginal estrogen

Urology Times staff
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
Comparable efficacy seen with single vs. multiple OnabotulinumtoxinA injection sites in OAB
October 24th 2024

Comparable efficacy seen with single vs. multiple OnabotulinumtoxinA injection sites in OAB

Hannah Clarke
At 1 month, the mean decrease in the OAB-Q symptom severity subscale score was -31.2 in the 1-injection cohort vs -39.5 in the 10-injection cohort.
Healthy diet may lower risk of grade reclassification in patients with GG1 prostate cancer
October 24th 2024

Healthy diet may lower risk of grade reclassification in patients with GG1 prostate cancer

Hannah Clarke
Patients with higher baseline HEI and E-HEI scores were less likely to experience grade reclassification.
© 2024 MJH Life Sciences

All rights reserved.